Posted by Michael Wonder on 29 May 2026
Foundayo and Zepbound now covered for millions of Americans
28 May 2026 - CVS Caremark begins covering Foundayo 1 June 2026 and resumes Zepbound coverage by 1 October 2026. Eligible patients may pay as low as $25/month for their medicine.
Eli Lilly and Company today announced an access milestone in obesity care: all three of the nation's largest pharmacy benefit managers will cover Lilly's full obesity medicine portfolio. This significantly expands the number of Americans who can access FDA approved options through their existing insurance.
